Follow
Dr. Kaviarasan Lakshmanan
Dr. Kaviarasan Lakshmanan
Department of pharmaceutical chmeistry, JSS College of Pharmacy
Verified email at jkkn.ac.in
Title
Cited by
Cited by
Year
Oral modified drug release solid dosage form with special reference to design; an overview
S Murugesan, B Gowramma, K Lakshmanan, VVS Reddy Karri, ...
Current Drug Research Reviews Formerly: Current Drug Abuse Reviews 12 (1), 16-25, 2020
262020
Promising pharmaceutical prospective of java olive-Sterculia foetida Linn (Sterculiaceae)
YG Prakash, V Gopal, L Kaviarasan
Int J Pharm Rev Res 2, 93-96, 2012
152012
Molecular docking studies and synthesis of a new class of chroman-4-one fused 1, 3, 4-thiadiazole derivatives and evaluation for their anticancer potential
L Kaviarasan, B Gowramma, R Kalirajan, M Mevithra, S Chandralekha
Journal of the Iranian Chemical Society 17, 2083-2094, 2020
132020
Antihyperlipidemic effect of Stevia rebaudiana on Alloxan induced diabetic rats
T Sudha, DA Devi, L Kaviarasan
Asian Journal of Pharmacy and Technology 7 (4), 202-208, 2017
112017
1, 3, 4-Thiadiazolo (3, 2-) Pyrimidine-6-Carbonitrile Scaffold as PARP1 Inhibitors
L Kaviarasan, E Eldhose, PT Krishnamurthy, K Rajagopal, M Mohammed, ...
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2021
92021
Preparation and Standardization of Deepavali Avaleha-A Traditional Polyherbal Ayurvedic Formulation
L Kaviarasan, S Sarojini, GP Yoganandam, V Gopal
Asian Journal of Pharmacy and Technology 6 (4), 231-237, 2016
92016
Chemical composition, antibacterial, anti-oxidant and cytotoxic properties of green synthesized silver nanoparticles from Annona muricata L.(Annonaceae)
SB Santhosh, MJN Chandrasekar, L Kaviarasan, P Deepak, ...
Research Journal of Pharmacy and Technology 13 (1), 33-39, 2020
82020
Identification of benzimidazole containing 4H–chromen–4–one derivative as potential MAP kinase inhibitors by in-silico approaches
K Lakshmanan, G Byran
Journal of Receptors and Signal Transduction 41 (2), 153-158, 2021
72021
Translational Chemotherapy for triple negative Breast Cancer-A Review on significance of poly (ADP-ribose) polymerase 1 (PARP 1) inhibitors
E Eldhose, B Gowramma, M Mohammed, R Kalirajan, L Kaviarasan
Research Journal of Pharmacy and Technology 12 (6), 3098-3104, 2019
72019
Synthesis and pharmacological evaluation of 1, 3, 4-thiadiazole bearing pyrimidine derivatives as STAT3 inhibitor for treatment of breast cancer
B Sravanthi, L Kaviarasan, TK Praveen, PSS Sai Kiran, C Pavankumar, ...
Journal of the Iranian Chemical Society 17, 2359-2370, 2020
62020
New stability chiral RP-HPLC method for degradation products determination in midodrine hydrochloride
G Byran, J Ashwini, K Lakshmanan, K Rajagopal, G Subramanian, ...
Drug Development and Industrial Pharmacy 47 (7), 1072-1078, 2021
42021
The Role of STAT3 Signaling in Different Types of Cancers: A Comprehensive Review
K Lakshmanan, G Byran, S Bandlamudi, PT Krishnamurthy
Current Enzyme Inhibition 16 (3), 189-198, 2020
42020
Enantiomeric separation of meclizine hydrochloride in pharmaceutical dosage form by HPLC method
B Gowramma, RS Kumar, R Kalirajan, K Lakshmanan, SN Meyyanathan
Current Drug Research Reviews Formerly: Current Drug Abuse Reviews 12 (1), 63-71, 2020
42020
Metabolic Enzyme Inhibitory and Larvicidal Activity of Biosynthesized and Heat Stabilized Silver Nanoparticles Using Annona muricata Leaf Extract
SB Santhosh, D Natarajan, P Deepak, B Gayathri, L Kaviarasan, ...
BioNanoScience 10, 267-278, 2020
42020
A brief review on dual target of PARP1 and STAT3 for cancer therapy: A novel perception
L Kaviarasan, B Gowramma, M Manal
Current Enzyme Inhibition 16, 1-20, 2020
42020
A review on biological activities: 1, 3, 4-thiadiazole and its derivatives
K Hemanth, K Lakshmanan, K Rajagopal
Education 2021, 2018
32018
An Update on Poly (ADP-ribose) Polymerase IA Brief Review
P Negi, K Lakshmanan, PK Patel, K Rajagopal, G Byran
Mini Reviews in Medicinal Chemistry 23 (18), 1762-1771, 2023
22023
Discovery of potential inhibitors for stat3: ligand based 3D pharmacophore, virtual screening, molecular docking, dynamic studies and in vitro evaluation
K Lakshmanan, P TK, SR K. Pai, K Rajagopal, G Byran
Journal of Biomolecular Structure and Dynamics 40 (21), 11320-11338, 2022
22022
A New Stability-indicating Chiral RP-HPLC Method for the Determination of Degradation Products in Meclizine Hydrochloride
B Gowramma, RS Kumar, K Lakshmanan, R Kalirajan, SN Meyyanathan
Current Pharmaceutical Analysis 17 (8), 1075-1087, 2021
22021
Development and validation of LC/MS method for the determination of meclizine enantiomers in pharmaceutical formulations
G Byran, SK Ramachandran, K Lakshmanan, K Rajagopal, ...
Drug Development and Industrial Pharmacy 47 (3), 361-366, 2021
22021
The system can't perform the operation now. Try again later.
Articles 1–20